Amundi’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,723
| Closed | -$455K | – | 2034 |
|
|
2025
Q1 | $455K | Sell |
18,723
-4,391
| -19% | -$107K | ﹤0.01% | 1511 |
|
|
2024
Q4 | $429K | Buy |
23,114
+15,431
| +201% | +$287K | ﹤0.01% | 1590 |
|
|
2024
Q3 | $120K | Buy |
7,683
+711
| +10% | +$11.1K | ﹤0.01% | 1754 |
|
|
2024
Q2 | $151K | Buy |
+6,972
| New | +$151K | ﹤0.01% | 1631 |
|
|
2022
Q4 | – | Sell |
-2,635
| Closed | -$149K | – | 1950 |
|
|
2022
Q3 | $149K | Hold |
2,635
| – | – | ﹤0.01% | 1494 |
|
|
2022
Q2 | $139K | Hold |
2,635
| – | – | ﹤0.01% | 1396 |
|
|
2022
Q1 | $214K | Hold |
2,635
| – | – | ﹤0.01% | 1377 |
|
|
2021
Q4 | $162K | Hold |
2,635
| – | – | ﹤0.01% | 1502 |
|
|
2021
Q3 | $148K | Hold |
2,635
| – | – | ﹤0.01% | 1459 |
|
|
2021
Q2 | $160K | Buy |
+2,635
| New | +$160K | ﹤0.01% | 1421 |
|